As obesity remains stubbornly prevalent and resistant to clinical remediation [66], these data suggest that new therapies to preserve health in the context of today’s complex environment could be based on manipulation of NOX2 signaling in macrophages. This evidence concerns the gene CYBB and obesity due to melanocortin 4 receptor deficiency.